The US FDA's Office of Drug Evaluation II Deputy Director Mary Thanh Hai will serve as acting director of the Division of Metabolism and Endocrinology Products following the departure of Director Jean-Marc Guettier.
“Dr. Guettier will be leaving the FDA for a position in the private sector,” FDA said in an email. “During...








